Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 102,604 | 91,313 | 95,115 | 83,448 | 84,107 |
| Cost of Goods | 25,201 | 27,303 | 23,979 | 19,065 | 20,916 |
| Gross Profit | 77,403 | 64,010 | 71,136 | 64,383 | 63,191 |
| Operating Expenses | 72,329 | 63,234 | 59,852 | 60,400 | 57,566 |
| Operating Income | 5,275 | 1,079 | 12,263 | 4,048 | 6,541 |
| Interest Expense | 5,878 | 5,814 | 5,753 | 5,642 | 5,397 |
| Other Income | 1,730 | 2,217 | 1,813 | 892 | 1,455 |
| Pre-tax Income | 1,127 | -2,518 | 8,323 | -702 | 2,599 |
| Income Tax | -1,603 | 253 | 38 | -62 | 35 |
| Net Income Continuous | 2,730 | -2,771 | 8,285 | -640 | 2,564 |
| Net Income | $2,730 | $-2,771 | $8,285 | $-640 | $2,564 |
| EPS Basic Total Ops | 0.07 | -0.07 | 0.21 | -0.02 | 0.06 |
| EPS Basic Continuous Ops | 0.07 | -0.07 | 0.20 | -0.02 | 0.06 |
| EPS Diluted Total Ops | 0.06 | -0.07 | 0.21 | -0.02 | 0.06 |
| EPS Diluted Continuous Ops | 0.06 | -0.07 | 0.21 | -0.02 | 0.06 |
| EBITDA(a) | $14,384 | $8,444 | $20,005 | $11,181 | $12,954 |